CTI 222 (Ciprofloxacin 250 mg)
Pill imprint CTI 222 has been identified as Ciprofloxacin hydrochloride 250 mg.
Ciprofloxacin is used in the treatment of urinary tract infection; bacterial infection; epididymitis, sexually transmitted; sinusitis; gonococcal infection, uncomplicated (and more), and belongs to the drug class quinolones. Risk cannot be ruled out during pregnancy. Ciprofloxacin 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- CTI 222
- Strength:
- 250 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Quinolones
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Carlsbad Technology, Inc.
- National Drug Code (NDC):
- 61442-0222
- Inactive Ingredients:
- hypromellose 2208 (15000 mPa.s)
lactose monohydrate
magnesium stearate
modified corn starch
sodium starch glycolate type A potato
titanium dioxide
triacetin
| NDC Code | Manufacturer / Repackager |
|---|---|
| 42291-0219 | AvKare, Inc. |
Note: Inactive ingredients may vary.
More about ciprofloxacin
Consumer resources
- Ciprofloxacin
- Ciprofloxacin extended-release tablets
- Ciprofloxacin suspension
- Ciprofloxacin tablets
- Ciprofloxacin injection
- More (2) »
- Other brands: Cipro, Cipro I.V., Cipro XR, Proquin XR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
